Understanding Low Risk MDS 2021 Fall Patient Family Conference @AAMDSIF

Uploaded January 2025 | Updated September 2026, 1 day ago

Suresh Balasubramanian, MD, with Karmanos Cancer Center, will provide a comprehensive overview of low risk myelodsyplastic syndromes (MDS). This session is suitable for patients, family members, caregivers and friends who are newly diagnosed and those who have been living with MDS for years. There will be a live Q & A session at the end of the presentation.

Understanding Low Risk MDS 2021 Fall Patient Family Conference

AAMDSIF 40th Anniversary Summit: Advances in the Science and Treatment of MDS

AAMDSIF 40th Anniversary Summit: Advances in MDS, Myelodysplastic Syndromes

Non-Transplant Therapies for Marrow Failure with Carlos DeCastro, MD and Phil Scheinberg, MD, PhD

FDA Approval of PiaSky for Pediatric Patients with PNH

Managing Treatment Symptoms with Diet with Joanna Myers Casale, RD, CSO

Treatments for MDS and Secondary AML - Part 2, High-Risk

Learn about newly approved oral medication for patients with PNH

Understanding Low Risk MDS 2021 Winter Patient Family Conference

High-Risk MDS and Secondary AML with Hetty Carraway, MD, MBA and Amer Zeidan, MD